The Rundown: ExL’s Blog
Viewing 11 to 20 of 28 records.
Media Roundup — Coverage from 5th Digital Marketing for Medical Devices
Friday September 18th, 2015
With more than 140 industry marketers, sales professionals and thought leaders in attendance at the 5th Digital Marketing for Medical Devices conference, this three-day event was a resounding success. The speakers were insightful and engaging, and delegates returned to work armed with best practices and new strategies to try in their workplaces — but don’t just take our word for it. These recaps will give you a glimpse of what you may have missed if you were unable to come to this event.
Words of Wisdom from Prolifiq and App Data…
Patient Medication Adherence Should Be a Priority in Our Healthcare System
Saturday September 12th, 2015
We live in a time when patients have more control over what kind of medications they take and how they take them. Though there are many positives associated with this freedom and the opportunities it presents, patient adherence has become a growing problem in our healthcare system. Many people fail to realize what can happen when individuals do not practice patient adherence, especially when it comes to taking their medication.
A CapGemini report estimates that the cost of poor medication adherence in the United States is as much as
Peter Shankman and Pharma Experts Weigh In: How “Niceness” Can Help Your Brand
Thursday September 3rd, 2015
This guest blog post is written by Dave Hochman. Dave is the owner of the Red Bank, NJ-based DJH Marketing Communications, Inc. For more information, go to www.djhmarcom.com, email email@example.com or follow Dave on Twitter @davehochman.
One of the first day’s speakers at Exl Pharma’s 11th Public Relations & Communications Summit at Sanofi US in July was Peter Shankman, a PR industry pundit and the author of such books as “Zombie Loyalists: Using Great Service to Create…
An Interview with Atul Mahableshwarkar, CNS Clinical Trial Forum Chair
Friday August 28th, 2015
|Conference chair Atul Mahableshwarkar, M.D., DFAPA|
CNS clinical trials are some of the most intricate, time-consuming processes modern life science professionals deal with. They necessitate a great deal of attention to detail and a strong commitment to quality from all involved parties. With ExL Events’ premiere CNS Clinical Trial Forum rapidly approaching, we spoke to conference chairperson Atul R. Mahableshwarkar, M.D., DFAPA, to learn more about him and his thoughts on this timely topic.
How did you become involved in…
The Value of Healthcare: Examining the Rising Cost of Prescription Drugs
Sunday August 23rd, 2015
Healthcare reform has been a major topic in America the last few years. Everyone wants to see the cost of staying healthy go down, or at least become affordable. The problem is those costs consist of several different factors. Getting control of expenses becomes difficult when one factor’s price rises. Such is the case with the increasing costs of prescription drugs.
Rising costs imperil the goal of maintaining good health and create the potential for greater costs in the long run. The obstacles presented by the inability…
Colleagues, Coffee and Communications — A Roundup of the #ExLPRSummit Coverage
Thursday August 13th, 2015
When the 11th Annual Public Relations & Communications Summit took place in July, more than 150 PR and comm professionals joined ExL Pharma at Sanofi’s New Jersey headquarters to participate in one of our favorite conferences of the year. We love engaging with our audience and hearing their thoughts, and are excited to share coverage of the event through their eyes with you.
What Attendees Had to Say
On the Makovsky Health blog, Group Vice President Rob Murphy discussed the importance of meaningful connections and value-added interactions….
A Groundbreaking Study in Latin America
Tuesday August 4th, 2015
Located in the northern hills of the Latin American country of Columbia, the secluded towns in the state of Antioquia give scientists a unique opportunity to study disease. As a result of its long-term isolation from newcomers, the intermarriage of residents has allowed genetic mutations to persist through generations.
Because the region’s gene pool has not experienced any significant genetic mingling, it is ideal for studying bipolar and cardiovascular disease, Alzheimer’s disease, and juvenile diabetes. Unlike general population studies requiring big data collection to tease out disease…
It’s Time to Get with the Programmatic!
Sunday July 26th, 2015
Recent studies show that leading life science companies have drastically improved their technology in order to enhance their product marketing, and it’s a no-brainer why they are doing this. Having the ability to choose which targeted audience you want your product to reach is becoming increasingly important, but how can you escalate exposure while cutting costs? Get with the programmatic!
Programmatic strategies can identify which customers you want to advertise to the quickest, and this customization can save your organization…
ExL Events’ December Conference Showcases Latest OTC Trends
Friday April 3rd, 2015
As highlighted by ExL Events’ Rx to OTC Summit Chairperson Steve Francesco of Francesco International, switches to OTC are on the rise in both volume and in generating sales. Indeed, as many as seven switches may be approved through 2016, and over the counter drug sales have increased with the recent switches of two high-profile allergy medications, Nexium 24HR and Nasacort Allergy 24HR.
In the coming years, switches will likely spread to medications that treat chronic diseases, a change that is sure to be a…
ExL Events’ December Content Marketing Program Makes the News!
Tuesday February 3rd, 2015
PM360 recently published an article discussing the engaging sessions that were presented at ExL’s 3rd Content Marketing for Life Sciences conference this past December. It highlights the key role content marketing has come to play in communications between life science companies and consumers. It also references some of the conference speakers, who came from companies like Becton Dickinson, Wego Health, American Medical Association, LinkedIn, Daiichi Sankyo and Eli Lilly to address some of the biggest issues life science marketers face today.
Read the full article over at